Infectious Disease In Vitro Diagnostics Market Outlook 2026–2030 Exploring New Business Opportunities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Infectious Disease In Vitro Diagnostics Market During 2026–2030?

The size of the infectious disease in vitro diagnostics market has shown robust growth over the past few years. This market is projected to expand from $15.1 billion in 2025 to reach $16.13 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical growth include the worldwide prevalence of infectious diseases, the expansion of hospital laboratories, a rising demand for prompt diagnosis, advancements in immunoassay technologies, and governmental initiatives for disease control.

The infectious disease in vitro diagnostics market is expected to experience substantial growth over the next few years. It is projected to expand to **$21.25 billion in 2030**, achieving a compound annual growth rate (CAGR) of **7.1%**. This anticipated growth during the forecast period can be attributed to pandemic preparedness measures, the expansion of molecular diagnostics, increasing antimicrobial resistance, the proliferation of diagnostic laboratories, and enhanced healthcare screening. Significant trends in the forecast period include the rapid adoption of molecular diagnostics, point-of-care infectious testing, highly sensitive pathogen detection, the use of multiplex diagnostic panels, and an increase in surveillance testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30303&type=smp

Which Economic Or Industry Drivers Are Impacting The Infectious Disease In Vitro Diagnostics Market?

The rising worldwide occurrence of infectious diseases stimulated the expansion of the infectious disease in vitro diagnostics market over the historical period. Infectious diseases pertain to the global number of individuals suffering from bacterial, viral, fungal, or parasitic infections at any given moment, reflecting the total disease load across populations. Environmental shifts, specifically climate change, have enlarged the dwelling areas for disease-transmitting vectors like mosquitoes, contributing to an uptick in the worldwide occurrence of infectious diseases. The infectious disease in vitro diagnostics facilitate this progression by offering accurate and prompt diagnostic instruments, empowering healthcare professionals to pinpoint pathogens, commence suitable treatment, and manage outbreaks with greater efficacy. As an illustration, in October 2024, the World Health Organization, a Switzerland-based health authority, reported that around 10.8 million people globally contracted tuberculosis, wherein 55% were men, 33% women, and 12% children and adolescents, with individuals living with human immunodeficiency virus (HIV) constituting 6.1% of these instances. Consequently, the growing worldwide presence of infectious diseases drove the expansion of the infectious disease in vitro diagnostics market throughout the historical period.

How Are The Various Segments Of The Infectious Disease In Vitro Diagnostics Market Categorized?

The infectious disease in vitro diagnostics market covered in this report is segmented –

1) By Product Type: Instruments, Reagents, Software And Services

2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology

3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications

4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers

2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators

3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services

What Trends Are Affecting The Expansion Of The Infectious Disease In Vitro Diagnostics Market?

Leading companies in the infectious disease in vitro diagnostics market are concentrating on developing innovative products, such as the swift identification of numerous gastrointestinal pathogens. This focus aims to facilitate timely diagnosis, enhance patient outcomes, and expand point-of-care testing capabilities. The rapid detection of multiple gastrointestinal pathogens refers to diagnostic assays designed to quickly pinpoint the presence of various disease-causing microorganisms in the gastrointestinal tract from a single sample. For instance, in June 2024, MP Biomedicals, a US-based supplier of a diverse range of products, chemicals, and diagnostics, unveiled a series of immunochromatographic-based rapid diagnostic kits for gastrointestinal infectious diseases. These kits enable the quick and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. Their features include rapid, point-of-care qualitative detection, versatile sample compatibility (covering stool, blood, plasma, serum, water, and food), and suitability for both clinical and research environments. By leveraging cutting-edge immunochromatographic technology, these kits support early diagnosis, aid in monitoring treatment effectiveness, and confirm pathogen eradication, thereby marking a significant advancement in gastrointestinal health diagnostics through their combination of speed, precision, and extensive pathogen coverage.

Which Major Firms Influence Developments In The Infectious Disease In Vitro Diagnostics Market?

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare

Read the full infectious disease in vitro diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/global-infectious-disease-in-vitro-diagnostics-market-report

What Are The Top-Performing Regions Within The Infectious Disease In Vitro Diagnostics Market?

North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infectious Disease In Vitro Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30303&type=smp

Browse Through More Reports Similar to the Global Infectious Disease In Vitro Diagnostics Market 2026, By The Business Research Company

Cogeneration Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cogeneration-equipment-global-market-report

Sterilization Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report

Respiratory Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795